Malcolm Ward - Proteome Sciences Insider

PRM -- UK Stock  

GBp 3.62  0.13  3.47%

Dr. Malcolm Ward is Chief Technical Officer London Research Facility of Proteome Sciences PLC. Malcolm Ward joined Proteome Sciences plc in May 2001 having previously worked for GlaxoWellcome for 12 years, in protein mass spectrometry. He was involved in the establishment of the new leading edge protein separation and mass spectrometry facility at the Institute of Psychiatry, Kings College London. His research team is involved in biomarker discovery, validation and assay development. His academic qualifications include a MS in Molecular Biology from the University of Hertfordshire in 1996 and a Graduateship from the Royal Society of Chemistry in 1992. He obtained a PhD in Applied Proteomics at Kings College, London in 2009..
  Executive Since 2011      
44 20 7043 2116

Management Efficiency

The company has return on total asset (ROA) of (13.16) % which means that it has lost $13.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (16.4) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 9.11 M in total debt. Proteome Sciences plc has Current Ratio of 0.3 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Found 7 records


Peter SpeirsHikma Pharmaceuticals PLC
Tony BunnSareum Holdings plc
Paul MussendenBTG plc
Hussein ArkhaghaHikma Pharmaceuticals PLC
Bryan HotstonHikma Pharmaceuticals PLC
Bassam KanaanHikma Pharmaceuticals PLC
Simon ThornRedx Pharma Plc

Entity Summary

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company was incorporated in 1993 and is headquartered in London, the United Kingdom. Proteome Sciences operates under Diagnostics Research classification in UK and traded on London Stock Exchange. It employs 34 people.Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Hamilton House and employs 34 people.

Proteome Sciences plc Leadership Team

William Dawson, Non-Executive Director
Roger McDowell, Non-Executive Director
Christopher Pearce, Chief Executive, Executive Director
Ian Pike, COO and Executive Director
Richard Dennis, Chief Commercial Officer
Malcolm Ward, Chief Technical Officer of London Research Facility
Martin Diggle, Non-Executive Director
Jeremy Haigh, CEO, Director
Josef Schwarz, Head of Projects and Production - Proteome Sciences RandD
Ursula Ney, Non-Executive Director
Glenn Barney, VP of Bus. Devel. - USA
Gee Chee, Director of Personalised Medicine
Geoffrey Ellis, Fin. Director, Company Secretary and Executive Director

Stock Performance Indicators

Did you try this?

Run Equity Forecasting Now

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Equity Forecasting
Currently Active Assets on Macroaxis
Purchased over 70 shares of
few hours ago
Traded for 40.5
Purchased a lot of shares of
few hours ago
Traded for 152.04
Purchased over 500 shares of
few hours ago
Traded for 6.01
Purchased over 30 shares of
few hours ago
Traded for 83.93
Purchased over 20 shares of
few hours ago
Traded for 107.66
Additionally take a look at Your Equity Center. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.